These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 24607562)
1. Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study. Bourne S; Cohet C; Kim V; Barton A; Tuck A; Aris E; Mesia-Vela S; Devaster JM; Ballou WR; Clarke SC; Wilkinson T BMJ Open; 2014 Mar; 4(3):e004546. PubMed ID: 24607562 [TBL] [Abstract][Full Text] [Related]
2. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Wilkinson TMA; Aris E; Bourne S; Clarke SC; Peeters M; Pascal TG; Schoonbroodt S; Tuck AC; Kim V; Ostridge K; Staples KJ; Williams N; Williams A; Wootton S; Devaster JM; Thorax; 2017 Oct; 72(10):919-927. PubMed ID: 28432209 [TBL] [Abstract][Full Text] [Related]
3. Early diagnostic BioMARKers in exacerbations of chronic obstructive pulmonary disease: protocol of the exploratory, prospective, longitudinal, single-centre, observational MARKED study. Waeijen-Smit K; DiGiandomenico A; Bonnell J; Ostridge K; Gehrmann U; Sellman BR; Kenny T; van Kuijk S; Peerlings D; Spruit MA; Simons SO; Houben-Wilke S; Franssen FME BMJ Open; 2023 Mar; 13(3):e068787. PubMed ID: 36868599 [TBL] [Abstract][Full Text] [Related]
4. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease. Ko FW; Chan PK; Chan RWY; Chan KP; Ip A; Kwok A; Ngai JC; Ng SS; On CT; Hui DS Respir Res; 2019 Sep; 20(1):210. PubMed ID: 31519188 [TBL] [Abstract][Full Text] [Related]
5. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA; Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298 [TBL] [Abstract][Full Text] [Related]
7. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial. Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y Trials; 2012 Apr; 13():40. PubMed ID: 22520863 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis. Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995 [No Abstract] [Full Text] [Related]
9. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study. Xiao W; Du LY; Mao B; Miao TW; Fu JJ BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612 [TBL] [Abstract][Full Text] [Related]
10. Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples. Alotaibi NM; Chen V; Hollander Z; Leipsic JA; Hague CJ; Murphy DT; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD Int J Chron Obstruct Pulmon Dis; 2019; 14():311-319. PubMed ID: 30774328 [TBL] [Abstract][Full Text] [Related]
11. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol. Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111 [TBL] [Abstract][Full Text] [Related]
12. Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD. Inoue S; Ikeda H Int J Chron Obstruct Pulmon Dis; 2019; 14():575-583. PubMed ID: 30880947 [TBL] [Abstract][Full Text] [Related]
13. Validation of acute exacerbation of chronic obstructive pulmonary disease (COPD) recording in electronic health records: a systematic review protocol. Stone P; Sood N; Feary J; Roberts CM; Quint JK BMJ Open; 2020 Feb; 10(2):e032467. PubMed ID: 32111611 [TBL] [Abstract][Full Text] [Related]
14. Phase III, two arm, multi-centre, open label, parallel-group randomised designed clinical investigation of the use of a personalised early warning decision support system to predict and prevent acute exacerbations of chronic obstructive pulmonary disease: 'Predict & Prevent AECOPD' - study protocol. Kaur D; Mehta RL; Jarrett H; Jowett S; Gale NK; Turner AM; Spiteri M; Patel N BMJ Open; 2023 Mar; 13(3):e061050. PubMed ID: 36914185 [TBL] [Abstract][Full Text] [Related]
15. Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study). Kenn K; Gloeckl R; Leitl D; Schneeberger T; Jarosch I; Hitzl W; Alter P; Sczepanski B; Winterkamp S; Boensch M; Schade-Brittinger C; Skevaki C; Holz O; Jones PW; Vogelmeier CF; Koczulla AR BMJ Open; 2021 Feb; 11(2):e043014. PubMed ID: 33558356 [TBL] [Abstract][Full Text] [Related]
16. Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study. Abrham Y; Zeng S; Lin W; Lo C; Beckert A; Evans L; Dunn M; Giang B; Thakkar K; Roman J; Blanc PD; Arjomandi M BMC Pulm Med; 2024 Sep; 24(1):433. PubMed ID: 39223571 [TBL] [Abstract][Full Text] [Related]
17. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data. Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101 [TBL] [Abstract][Full Text] [Related]
18. Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial. Xia R; Fei Y; Zhang L; Jie Z; Fan X; Dai M; Moore M; Willcox M; Hu X; Francis N; Liang C; Fei G; Liu J BMJ Open; 2023 Sep; 13(9):e070864. PubMed ID: 37775286 [TBL] [Abstract][Full Text] [Related]
19. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines. Reissig A; Mempel C; Schumacher U; Copetti R; Gross F; Aliberti S Lung; 2013 Jun; 191(3):239-46. PubMed ID: 23564195 [TBL] [Abstract][Full Text] [Related]
20. Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD, a longitudinal and cross-sectional study. Chang C; Zhu H; Shen N; Chen Y; He B; Zhao J; Yao W COPD; 2015 Feb; 12(1):19-30. PubMed ID: 24800883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]